APRISO: payments to doctors
Payments that named APRISO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $109K
- Providers
- 2,147
- Transactions
- 5,923
- Average per transaction
- $18
The per-transaction average — $18 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,147 providers the average total is $51, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $108,334 | 99.4% |
| Bausch & Lomb Americas Inc. | $509 | 0.5% |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $159 | 0.1% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $17 | 0.0% |